GlassScriptPhysician profile
William John Bontempi
NPI 1114958444
$93,015.16
in general payments reported to CMS, 2019-2025
8 companies · $167 in 2025
The $167 reported for 2025 was more than what a typical Oral and Maxillofacial Surgery provider received nationally (typical 2025 total: $150).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15K · 2020: $15K · 2021: $16K · 2022: $15K · 2023: $662 · 2024: $30K · 2025: $167.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $30K · Education: $465 · Food and Beverage: $264 · Entertainment: $137.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $30,000.00 |
| Education | $464.94 |
| Food and Beverage | $263.95 |
| Entertainment | $137.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Straumann USA LLC | $90,637.04 | 2019-2025 | |
| Salvin Dental Specialties, INC. | $1,270.74 | 2020-2021 | |
| Keystone Dental INC. | $1,008.89 | 2019-2025 | |
| Geistlich Pharma, North America, INC. | $43.35 | 2019-2022 | |
| Neoss, INC. | $21.41 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $14.82 | 2022 | |
| Zimvie INC. | $12.95 | 2022 | |
| Biolase, INC. | $5.96 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Bontempi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.